Jason Eades

Director at Revi Life Sciences.

Earliest Form D on file: Apr 2025

2 filings at 1 company

Revi Life Sciences

Biotech, Austin TX

Director · signer

Biotech, Austin TX

Signed
Named
AmendmentAmendment of an earlier filing
Size is amount sold, up to $30M

Filings

2 filings · 1 offering

Apr 7, 2025
Security to be acquired, signed · Form D
$340K
Apr 7, 2025
Latest Apr 7, 2025
Security to be acquired
Signed as Director
$340K
—
Form D
1 amendmentLatest Apr 7, 2025
- Apr 7, 2025$340KForm D
  Apr 7, 2025$340KForm D